Literature DB >> 15227842

[Multiple intracranial aneurysms and vascular abnormalities associated with neurofibromatosis type 1: a case report].

Motoaki Fujimoto1, Ichiro Nakahara, Masato Tanaka, Yasushi Iwamuro, Yoshihiko Watanabe, Kei Harada.   

Abstract

We present an unusual case of multiple intracranial aneurysms, persistent primitive trigeminal artery (PPTA), and fenestration of the middle cerebral artery (MCA), associated with type 1 neurofibromatosis (NF 1). The patient was a 55-year-old woman in a state of semicoma. We observed widespread neurofibromas and café au lait spots on her trunk and limbs. Computed tomography (CT) scan revealed diffuse subarachnoid hemorrhage and right frontal intracerebral hemorrhage (WFNS grade IV, Fisher's classification group 4). Cerebral angiography showed two intracranial aneurysms at the anterior communicating artery, an aneurysm at the cavernous portion of the right carotid artery, a PPTA, and MCA fenestration. The patient remained in an apallic state, even after successful clipping of the anterior communicating artery aneurysms.

Entities:  

Mesh:

Year:  2004        PMID: 15227842

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  3 in total

1.  Cerebral aneurysm in the long fenestration at the middle portion of m1 segment.

Authors:  Ki-Bum Sim; Chang Sub Lee; Jung Cheol Park; Ji Soon Huh
Journal:  J Korean Neurosurg Soc       Date:  2010-11-30

Review 2.  Coil embolisation of multiple cerebral aneurysms with lateral type I persistent primitive trigeminal artery: A case report and literature review.

Authors:  Zheng Wan; Hao Meng; Ning Xu; Tianyi Liu; Zhongping Chen; Zheming Zhang; Jianjun Xu; Honglei Wang
Journal:  Interv Neuroradiol       Date:  2019-06-20       Impact factor: 1.610

3.  Extracranial vertebral artery aneurysm associated with neurofibromatosis type 1. A case report.

Authors:  H Hiramatsu; M Negoro; M Hayakawa; A Sadatou; K Irie; A Uemura; T Kanno; K Sano
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.